Stay updated with breaking news from Scientific Founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug development and FDA approval, is the first gene-editing medical treatment to recieve FDA approval.
SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2024--
Operator: Greetings. Welcome to the Protagenic Therapeutics' Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco. The J.P. Morgan Healthcare Conference has...
SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco.